Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018 (2018), Article ID 6462793, 15 pages
https://doi.org/10.1155/2018/6462793
Research Article

Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose

1Department of Endoscope, The First Hospital Affiliated to China Medical University, Shenyang, Liaoning, China
2Department of Endocrinology, The Second People’s Hospital of Fuxin City, Fuxin, Liaoning, China
3Department of Endocrinology, The First Hospital Affiliated to China Medical University, Shenyang, Liaoning, China

Correspondence should be addressed to Qiuyue Wang; moc.361@321umcyqw

Received 9 July 2017; Revised 10 December 2017; Accepted 3 January 2018; Published 21 February 2018

Academic Editor: Małgorzata Kotula-Balak

Copyright © 2018 Can Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. Y. Wang, Q. H. Guan, and F. Q. Chen, “The changes of platelet-derived growth factor-BB (PDGF-BB) in T2DM and its clinical significance for early diagnosis of diabetic nephropathy,” Diabetes Research and Clinical Practice, vol. 85, no. 2, pp. 166–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Huang, C. T. Chuang, M. H. Liu, S. H. Lin, J. Y. Guh, and L. Y. Chuang, “Klotho attenuates high glucose-induced fibronectin and cell hypertrophy via the ERK1/2-p38 kinase signaling pathway in renal interstitial fibroblasts,” Molecular and Cellular Endocrinology, vol. 390, no. 1-2, pp. 45–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. V. P. Sukhatme, “The Egr transcription factor family: from signal transduction to kidney differentiation,” Kidney International, vol. 41, no. 3, pp. 550–553, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Wang, M. P. Guan, Z. J. Zheng et al., “Transcription factor Egr1 is involved in high glucose-induced proliferation and fibrosis in rat glomerular mesangial cells,” Cellular Physiology and Biochemistry, vol. 36, no. 6, pp. 2093–2107, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. L. C. Ho, J. M. Sung, Y. T. Shen et al., “Egr-1 deficiency protects from renal inflammation and fibrosis,” Journal of Molecular Medicine, vol. 94, no. 8, pp. 933–942, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Vedantham, D. Thiagarajan, R. Ananthakrishnan et al., “Aldose reductase drives hyperacetylation of Egr-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals,” Diabetes, vol. 63, no. 2, pp. 761–774, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. M. Ha, E. J. Park, Y. J. Kang, S. W. Park, H. J. Kim, and K. C. Chang, “Valsartan independent of AT1 receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions,” Journal of Cellular and Molecular Medicine, vol. 18, no. 10, pp. 2031–2043, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Zheng, H. Chen, J. Li et al., “Sirtuin 1–mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin,” Diabetes, vol. 61, no. 1, pp. 217–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Foretz, B. Guigas, L. Bertrand, M. Pollak, and B. Viollet, “Metformin: from mechanisms of action to therapies,” Cell Metabolism, vol. 20, no. 6, pp. 953–966, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. D. R. Morales and A. D. Morris, “Metformin in cancer treatment and prevention,” Annual Review of Medicine, vol. 66, no. 1, pp. 17–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Bao, A. S. Azmi, S. Ali, F. Zaiem, and F. H. Sarkar, “Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers,” Annals of Translational Medicine, vol. 2, no. 6, p. 59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Arunachalam, S. M. Samuel, I. Marei, H. Ding, and C. R. Triggle, “Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1,” British Journal of Pharmacology, vol. 171, no. 2, pp. 523–535, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R. C. Cavaglieri, R. T. Day, D. Feliers, and H. E. Abboud, “Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction,” Molecular and Cellular Endocrinology, vol. 412, pp. 116–122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Amador-Licona, J. M. Guízar-Mendoza, E. Vargas, G. Sánchez-Camargo, and L. Zamora-Mata, “The short-term effect of a switch from glybenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus,” Archives of Medical Research, vol. 31, no. 6, pp. 571–575, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Katsura, A. Morishita, H. Iwama et al., “MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis,” International Journal of Molecular Medicine, vol. 35, no. 4, pp. 877–884, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Yamakuchi, M. Ferlito, and C. J. Lowenstein, “miR-34a repression of SIRT1 regulates apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 36, pp. 13421–13426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. X. Ding, M. Li, X. Y. Wan et al., “Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease,” Scientific Reports, vol. 5, no. 1, article 13729, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Zhang, S. Y. He, S. D. Guo et al., “Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1,” Journal of Diabetes and its Complications, vol. 28, no. 3, pp. 259–264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Fukao, Y. Fukuda, K. Kiga et al., “An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling,” Cell, vol. 129, no. 3, pp. 617–631, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Wu, C. Lv, F. Q. Chen, X. Y. Ma, Y. Shao, and Q. Wang, “The function of miR-199a-5p/Klotho regulating TLR4/NF-κB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism,” Molecular and Cellular Endocrinology, vol. 417, pp. 84–93, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. E. S. Koh, J. H. Lim, M. Y. Kim et al., “Anthocyanin-rich Seoritae extract ameliorates renal lipotoxicity via activation of AMP-activated protein kinase in diabetic mice,” Journal of Translational Medicine, vol. 13, no. 1, p. 203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Fu, S. Seok, S. Choi et al., “MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function,” Molecular and Cellular Biology, vol. 34, no. 22, pp. 4130–4142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Y. Wang and F. Q. Chen, “Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 83, no. 2, pp. 215–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. S. Duffield, “Cellular and molecular mechanisms in kidney fibrosis,” Journal of Clinical Investigation, vol. 124, no. 6, pp. 2299–2306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. K. C. Leung, M. Tonelli, and M. T. James, “Chronic kidney disease following acute kidney injury—risk and outcomes,” Nature Reviews Nephrology, vol. 9, no. 2, pp. 77–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. G. T. Tucker, C. Casey, P. J. Phillips, H. Connor, J. D. Ward, and H. F. Woods, “Metformin kinetics in healthy subjects and in patients with diabetes mellitus,” British Journal of Clinical Pharmacology, vol. 12, no. 2, pp. 235–246, 1981. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Allen, H. Jaeschke, and B. L. Copple, “Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis,” The American Journal of Pathology, vol. 178, no. 1, pp. 175–186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. F. Yan, T. Fujita, J. Lu et al., “Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress,” Nature Medicine, vol. 6, no. 12, pp. 1355–1361, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. R. N. Hasan, S. Phukan, and S. Harada, “Differential regulation of early growth response gene-1 expression by insulin and glucose in vascular endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 6, pp. 988–993, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Nakamura, Y. Isaka, M. Tsujie et al., “Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial α-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats,” Gene Therapy, vol. 9, no. 8, pp. 495–502, 2002. View at Publisher · View at Google Scholar
  32. G. Suchankova, L. E. Nelson, Z. Gerhart-Hines et al., “Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells,” Biochemical and Biophysical Research Communications, vol. 378, no. 4, pp. 836–841, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Reddy, W. Jin, L. Villeneuve et al., “Pro-inflammatory role of microRNA-200 in vascular smooth muscle cells from diabetic mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 3, pp. 721–729, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Lv, Y. H. Zhou, C. Wu, Y. Shao, C. L. Lu, and Q. Y. Wang, “The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy,” Diabetes/Metabolism Research and Reviews, vol. 31, no. 7, pp. 717–724, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. E. I. Silvio, J. L. Kasia, M. Helen, J. B. Clifford, and K. M. Darren, “Metformin in patients with type 2 diabetes and kidney disease: a systematic review,” JAMA, vol. 312, no. 24, pp. 2668–2675, 2014. View at Publisher · View at Google Scholar · View at Scopus